Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.
Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

Market Analysis and Insights: Global Infectious Disease Therapeutics Market
The global Infectious Disease Therapeutics market size is projected to reach US$ 47580 million by 2026, from US$ 45730 million in 2020, at a CAGR of 3.7%% during 2021-2026.

Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Novartis AG
Gilead
GlaxoSmithKline plc
Janssen Pharmaceutical Inc.
F. Hoffmann-La Roche Ltd.
BioCryst Pharmaceuticals Inc.
Merck & Co. Inc.
Boehringer Ingelheim GmbH

Market segment by Type, the product can be split into

Drugs
Vaccines

Market segment by Application, split into

HIV/AIDS
Influenza
Hepatitis
Malaria
Tuberculosis
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India